Please login to the form below

Data by

20

Revenue 2014

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

reactivating drug research programmes

Currently awaiting a possible Supreme Court hearing in the UK, the case of Warner-Lambert v Actavis will determine what conditions have to be met for a medical use claim to ... In fact, in light of Warner-Lambert v Actavis, pharmaceutical companies

MSD probed by UK for blocking Remicade biosimilars

Last year it fined Pfizer £84m for conspiring with Flynn Pharma to raise the price of epilepsy drug phenytoin, and has since launched an investigation into the pricing of Actavis' hydrocortisone

EU starts investigation of Aspen's cancer drug pricing

launched an investigation into the pricing of Actavis' hydrocortisone tablets.

Change at the top at Teva as Vigodman departs

is struggling to absorb an Actavis generics unit it bought for around $40bn last year. ... Peterburg said the "immediate focus" is "realising the cost synergies and strategic benefits of the Actavis generics acquisition".

Teva Generics Europe appoints president and CEO

Daniell has over 25 years of experience working at Teva and served as the company's chief integration officer, leading the integration programme to bring Actavis and Teva together.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 5)

Global revenue 2014
1: Novartis
2: Pfizer
3: Roche
4: Sanofi
5: Merck & Co.
6: Johnson & Johnson
7: GlaxoSmithKline
8: AstraZeneca
9: Gilead Sciences
10: Takeda
11: AbbVie
12: Amgen
13: Teva
14: Lilly
15: Bristol-Myers Squibb
16: Bayer
17: Novo Nordisk
18: Astellas
19: Boehringer Ingelheim
20: Actavis
21: Otsuka
22: Daiichi Sankyo
23: Biogen Idec
24: Baxter
25: Merck KGaA

US revenue 2014
1: Gilead Sciences
2: Johnson & Johnson
3: Pfizer
4: Roche
5: Novartis
6: Amgen
7: Merck & Co.
8: Sanofi
9: AbbVie
10: Actavis
11: AstraZeneca
12: GlaxoSmithKline
13: Lilly
14: Bristol-Myers Squibb
15: Novo Nordisk

CNS revenue 2014
1: Pfizer
2: Biogen Idec
3: Novartis
4: Otsuka
5: Teva
6: Johnson & Johnson
7: Lilly
8: Merck KGaA
9: AstraZeneca
10: Shire
11: Bristol-Myers Squibb
12: UCB
13: Lundbeck
14: Eisai
15: GlaxoSmithKline
16: Sanofi
17: Mylan
18: Indivior
19: Actavis
20: Bayer

Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com